Drug Type Biosimilar, Monoclonal antibody |
Synonyms Adalimumab Biosimilar (Genor Biopharma Co., Ltd.), 重组抗肿瘤坏死因子-α全人源单抗 (嘉和生物), 阿达木单抗生物类似药(Genor Biopharma Co., Ltd.) + [1] |
Target |
Action inhibitors |
Mechanism TNF-α inhibitors(Tumor necrosis factor α inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rheumatoid Arthritis | Phase 1 | China | - |